Variant report
Variant | rs7746841 |
---|---|
Chromosome Location | chr6:27261700-27261701 |
allele | C/G |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:27258000-27261800 | ZNF genes & repeats | Pancreatic Islets | Pancreatic Islet |
2 | chr6:27259400-27263400 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr6:27259400-27263600 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr6:27261000-27261800 | ZNF genes & repeats | Psoas Muscle | Psoas |
5 | chr6:27261000-27263800 | Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
6 | chr6:27261000-27264600 | Bivalent/Poised TSS | iPS-20b Cell Line | embryonic stem cell |
7 | chr6:27261000-27264600 | ZNF genes & repeats | Primary hematopoietic stem cells short term culture | blood |
8 | chr6:27261000-27265600 | Bivalent/Poised TSS | iPS-15b Cell Line | embryonic stem cell |
9 | chr6:27261000-27266400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
10 | chr6:27261000-27266400 | Bivalent/Poised TSS | HUES64 Cell Line | embryonic stem cell |
11 | chr6:27261000-27266800 | Active TSS | A549 | lung |
12 | chr6:27261200-27262000 | Active TSS | iPS DF 6.9 Cell Line | embryonic stem cell |
13 | chr6:27261200-27262200 | Active TSS | NHEK | skin |
14 | chr6:27261200-27262400 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr6:27261200-27262400 | Active TSS | Osteobl | bone |
16 | chr6:27261200-27263400 | ZNF genes & repeats | GM12878-XiMat | blood |
17 | chr6:27261200-27263600 | Active TSS | HUES48 Cell Line | embryonic stem cell |
18 | chr6:27261400-27261800 | Flanking Active TSS | HMEC | breast |
19 | chr6:27261400-27261800 | Flanking Active TSS | K562 | blood |
20 | chr6:27261400-27262000 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
21 | chr6:27261400-27262200 | Active TSS | H1 Cell Line | embryonic stem cell |
22 | chr6:27261400-27266400 | Active TSS | H9 Cell Line | embryonic stem cell |
23 | chr6:27261400-27266400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
24 | chr6:27261400-27266400 | Bivalent/Poised TSS | iPS-18 Cell Line | embryonic stem cell |
25 | chr6:27261600-27261800 | Active TSS | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
26 | chr6:27261600-27261800 | Flanking Active TSS | Foreskin Fibroblast Primary Cells skin01 | Skin |
27 | chr6:27261600-27261800 | Bivalent Enhancer | Fetal Muscle Trunk | muscle |
28 | chr6:27261600-27262200 | Bivalent/Poised TSS | HepG2 | liver |
29 | chr6:27261600-27262600 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
30 | chr6:27261600-27263000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
31 | chr6:27261600-27263200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
32 | chr6:27261600-27263200 | Weak transcription | HSMMtube | muscle |
33 | chr6:27261600-27263400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
34 | chr6:27261600-27263400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
35 | chr6:27261600-27264600 | Active TSS | IMR90 fetal lung fibroblasts Cell Line | lung |